Related Experiment Video
Updated: Jul 20, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Studying co-medication patterns: the impact of definitions
Hilde Tobi1, Adrianne Faber, Paul B van den Berg
1Department of Social Pharmacy, Groningen University Institute for Drug Exploration, Pharmacoepidemiology and Pharmacotherapy, Groningen, The Netherlands. hilde.tobi@wur.nl
Distinguishing drug co-medication patterns is crucial for accurate patient data. Different prescribing patterns significantly impact estimates of co-medication, affecting clinical insights and drug safety surveillance.
Area of Science:
- Pharmacovigilance
- Health Informatics
- Clinical Pharmacy
Background:
- Co-medication, the concurrent use of multiple drugs, is common but complex to quantify.
- Accurate assessment of co-medication is vital for drug safety and effective treatment.
- Existing methods may not adequately differentiate prescribing patterns, leading to potential misinterpretation of data.
Purpose of the Study:
- To highlight the necessity of differentiating various drug prescribing patterns that contribute to co-medication.
- To demonstrate the utility of large pharmacy and reimbursement databases for investigating these patterns.
- To emphasize how distinct co-medication patterns influence study outcomes.
Main Methods:
- Utilized large-scale pharmacy and reimbursement databases for analysis.
- Investigated two specific co-medication scenarios: antidepressants with anticonvulsants and antihistamines with penicillins.
- Analyzed data for specific periods to assess changes and proportions.
Main Results:
- Co-medication proportions varied significantly based on the definition and time frame studied.
- Estimates for antidepressant use among anticonvulsant users ranged from 5.8% to 14.5% in 2000.
- Antihistamine use among penicillin recipients ranged from 0.5% to 9.7% in 2000, with notable increases by 2002.
Conclusions:
- The choice of co-medication pattern significantly impacts clinical and statistical estimates, sometimes by a factor of 12.
- Proposed distinguishing between 'co-prescribing', 'concomitant medication,' and 'possibly concurrent medication.'
- Emphasized that the research question and the specific drugs/diseases dictate the appropriate co-medication pattern and time window for analysis.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Dosage Regimens: Designs and Approaches
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Therapy
Antianxiety Medications
Measurement of Bioavailability: Pharmacodynamic Methods